SCHEMBL25699162

SCHEMBL25699162

CCNS(=O)(=O)c1sc(C#N)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
CYP2C9 P11712 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PGR P06401 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP19A1 P11511 2/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
KDM4E B2RXH2 1/20 0.33
VCAM1 P19320 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
BRD4 O60885 1/20 0.32
BRD2 P25440 1/20 0.32
BRD3 Q15059 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25246994 0.82 PGR (0.35) PGR
SCHEMBL25699160 0.78 PGR (0.36) ALDH1A1PGRPKMKDM4ECA1
SCHEMBL9864782 0.67 PSIP1 (0.31)
SCHEMBL25420324 0.67 CTSL (0.37)
SCHEMBL16492321 0.66 ALDH1A1 (0.65) ALDH1A1CYP2C9SMN1; SMN2KMT2AVCAM1
SCHEMBL12763788 0.65 KDM4E (0.34) ALDH1A1SMN1; SMN2PGRMEN1KMT2A
SCHEMBL4613568 0.65 CYP19A1 (0.67) ALDH1A1CYP2C9CYP19A1
SCHEMBL4615617 0.64 PGR (0.50) ALDH1A1SMN1; SMN2PGRKMT2ACYP19A1
SCHEMBL13620942 0.63
SCHEMBL5007597 0.62 ALDH1A1 (0.41) ALDH1A1CYP2C9SMN1; SMN2PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed